When a Californian company founded by a U.S. veteran wounded in Afghanistan sought to register a new medical device this year, it turned to Europe before the United States. The European approvals system had long been quicker, the company said, but the introduction of new rules is changing all that. “Now it has flipped,” said Bill Colone, CEO of San Clemente-based Spinal Singularity, which hopes to launch a ‘smart’ catheter for men with spinal injuries or disease early next year after squeezing in its application under the old European rules. Colone is part of a chorus of industry voices warning that a switch to stricter European rules governing medical devices, due to come into force a year from now, will slow or even halt the release of products in Europe that could transform patients’ lives. Defenders of the regulations say they will not significantly complicate the process and are vital to prevent problems like rupturing silicone breast implants and debris from all-metal hip implants damaging tissue and bones. Many patient advocates say the new rules do not go far enough to reform a European system in which a top U.S. official suggested in 2011 patients may be “guinea pigs” here. The comment drew a sharp response from the European Union, which still firmly rejects that characterization. That transatlantic spat, and the subsequent evolution of medical device certification around the world, are part of a wider global struggle by governments to attract businesses seeking light-touch regulation without scaring off their voters. The new medical devices rules agreed by the European Union in 2017 will tighten control of devices before they come to market, improve transparency and strengthen surveillance by national authorities, a European Commission spokesperson said. The new system changes less than some proposals – which envisaged regulation by a public body, along U.S. lines, replacing the existing practice of certification by profit-making private firms. But players in medical technology – which ranges from surgical implants to scans – say it is too burdensome and is being built too slowly, risking not only hampering innovation but also harming patients by interrupting supplies. “Immediate action is needed now to avoid severe disruption of product supply to patients and hospitals,” seven European Associations said in a joint statement last week. All 55,000 devices certified under the old directives have to be re-certified along with other products such as reusable scalpels, nasal saline sprays and dental imaging software. The industry says there are not enough Notified Bodies – the private firms charged with certifying the safety of devices ranging from bandages to pacemakers, and that manufacturers may have to take products off the market or delay new launches.
Reutershttps://tinyurl.com/yyqe7pp3
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:35:292020-08-26 14:35:45Will Europe’s clampdown on faulty medical devices hurt patients?
Cytel has launched an open-access global COVID-19 Clinical Trial Tracker to help facilitate greater collaboration between researchers, policymakers, clinicians, journalists, philanthropists, and other critical stakeholders who need to understand the complex dynamics of the global response to finding a solution to the COVID-19 outbreak.
The tracker will enable them to make more informed and pragmatic decisions on how to channel scarce resources. Clinicians and local government need to know what trials are taking place in their community to ensure that the right patients receive the right exploratory treatment, while philanthropists and policymakers deserve a one-stop shop to determine which are the most promising early phase treatment results.
Funded in part by The Bill and Melinda Gates Foundation, this live dashboard offers an overview of all the trials taking place in the international effort to tackle the pandemic.
Joshua Schultz, Chief Executive Officer at Cytel, explained, "While much of the world is isolating, the scientific and clinical communities are coming together to fight the COVID-19 virus. United by an unprecedented sense of urgency, there is a level of collaboration that we’ve not seen before, and, despite the current pressures on the healthcare system, hundreds of hospitals are still committed to working on clinical trials. At Cytel, we have been supporting numerous clients in developing statistically rigorous models for fast data analysis and addressing the various challenges the pandemic presents in the current clinical environment. We are committed to supporting the global effort – and launching the COVID-19 Clinical Trial Tracker offered an additional way to do that."
To access Cytel’s Covid-19 Clinical Trial Tracker, visit: www.covid19-trials.com
The IHF World Hospital Congress is a unique global forum that brings together leaders of hospitals, health services, and healthcare organizations to discuss key drivers of national and international policy, management, financial trends and solutions. The 44th edition of the World Hospital Congress will take place on 2 to 5 November, 2020 at the Palau de Congressos de Catalunya in Barcelona. Professionals from the health sector interested in sharing their work to the international healthcare community are now invited to submit their abstracts. The International Hospital Federation and La Unió Catalana d’Hospitals, organizers of the congress, invite leaders and professionals from hospitals, health services, and healthcare organizations to submit abstracts for an opportunity to showcase their best practices, innovations, projects, programs and researches to over a thousand peers from around the world. The congress will tackle the overarching theme “People on board, transforming healthcare”. “The demands of the society and industry have forced healthcare to transform in ways we wouldn’t have imagined before. And now that transformations are very well in motion, there is so much for us to understand and implement,” said Prof. Antoni Trilla, Chair of the Scientific Committee of the World Hospital Congress. Those interested to present their work through an oral presentation or as a poster can submit abstracts online under the following sub-themes: DIGITAL AND TECHNOLOGY DRIVEN TRANSFORMATIONS · Artificial Intelligence for smart health and care · Big accurate data: how it helps us · How is digital health transforming the way health systems are run and healthcare is delivered · Glocalization: new actors, new rules, global healthcare invaders in the local healthcare set TOWARDS AN INTEGRATED CONCEPT OF HEALTH AND CARE SERVICES MODEL: VALUE DRIVEN TRANSFORMATIONS · Enabling the flexibility of organizations to adapt quickly to changes, addressing accelerated innovation adoption · Key results that really matter: patients outcomes as the driver for better healthcare · Health and care sustainability supported by applied research and innovation adoption · Global Healthcare, global mobility, global access: towards a liquid borderless healthcare system PEOPLE AT THE CENTER OF HEALTHCARE SYSTEM TRANSFORMATIONS · How to put citizens at the center of health and care · Humanistic centered care · Professionals leading transformations: the strength of professionals to promote transformation · From health management to ethical leadership Deadline of submission is on 31 January 2020. For more details and to submit your abstracts, go to https://worldhospitalcongress.org/2020-call-for-papers-and-posters.https://www.ihf-fih.org/https://www.uch.cat/Email: Mylene.dayola@ihf-fih.org
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:35:292020-08-26 14:35:40Call for abstracts is now open for the 44th World Hospital Congress in Barcelona (Spain)
The Messe Düsseldorf Group is re-focusing their activities on the health market in Brazil and will organize the first MEDICAL FAIR BRASIL from May 5 – 8, 2020 at the Expo Center Norte in Sao Paulo. It will be an annual event. MEDICAL FAIR BRASIL is supported by and staged in cooperation with the Brazilian medical technology manufacturers association ABIMO. Messe Düsseldorf’s foreign representation in Brazil is responsible for organizing the event. “With Messe Düsseldorf and ABIMO, two strong partners are working on the mutual goal of establishing MEDICAL FAIR BRASIL as Brazil’s leading event platform. Using our global network of 75 foreign representations and 12 affiliated companies or subsidiaries, we promote the event in over 130 countries and contribute our valuable experience in organizing medical trade fairs,” explained Wolfram Diener, Managing Director of Messe Düsseldorf. The Messe Düsseldorf Group has been organizing successful healthcare events around the globe for many years. In 2017, these healthcare events were grouped under the new umbrella brand “MEDICAlliance” in order to be marketed as a unit worldwide. In addition to the world-leading trade fair MEDICA and the internationally leading supplier trade fair COMPAMED (held concurrently in Düsseldorf, Germany) , the alliance includes MEDICAL FAIR INDIA (Mumbai/New Delhi), MEDICAL FAIR ASIA (Singapore), MEDICAL FAIR THAILAND (Bangkok) and MEDICAL FAIR CHINA (Suzhou). For the South American market, MEDICAL FAIR BRASIL is now being added as a further member of MEDICAlliance. Meditech in Colombia (Bogota) already successfully represents MEDICAlliance in South America. “We know the market and are already well connected in the industry in Brazil thanks to our previous commitments. For us, it is strategically important to have a strong presence on this market with MEDICAlliance. Positive growth prospects and Brazilian business partners, who in our experience are reliable and sincere, are the ideal foundation on which to build a top business,” said Horst Giesen, Global Portfolio Director Health & Medical Technologies at Messe Düsseldorf. The Brazilian market’s volume for medical technology is approximately $ 5.7 billion (source: gtai) and the healthcare industry is among the industries with the highest growth rates in the country. Paulo Fraccaro, Superintendent at ABIMO, is also looking forward to the cooperation for MEDICAL FAIR BRASIL: “The cooperation between ABIMO and Messe Düsseldorf will bring forth a strong alliance. Together, we are creating the ideal platform for companies to present their innovations and meet relevant decision-makers – both those active in health care as well as manufacturers and distributors in other countries.” Key exhibit categories at MEDICAL FAIR BRASIL are: Medical technology / medical products, laboratory technology and diagnostics, health IT, physiotherapy and orthopedic technology as well as medical services. The trade fair primarily addresses physicians, medical professionals and managers of health institutions as well as health industry service suppliers and experts in the fields of science, politics, trade and industry. http://www.medicalfair-brasil.com www.mdna.com http://abimo.org.br
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:35:292020-08-26 14:35:48Messe Düsseldorf Group to organize new MEDICAL FAIR BRASIL
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:35:292020-08-26 14:35:35Robot used to treat brain aneurysms for the first time
The 43rd IHF World Hospital Congress kicks off today at the Oman Convention and Exhibition Centre for four days of insightful discussions and knowledge exchange among health leaders from 59 countries, all gathered together to improve the way we deliver healthcare. Hosted by the Ministry of Health of the Sultanate of Oman, the World Hospital Congress, under the umbrella of the International Hospital Federation (IHF), is a unique global forum that brings health leaders from across the globe together annually to share views and experiences, network and promote excellence in healthcare and hospital leadership. “The Ministry of Health of the Sultanate of Oman is delighted to host the 43rd World Hospital Congress and welcome delegates from different countries and cultures to Muscat”, said Dr Qasem Ahmed Al Salmi, Chair of the 2019 World Hospital Congress Organizing Committee. “In the next four days we will hear accounts about resiliency, investments, and innovations; and understand better the interconnected roles of hospitals, patients, and communities in times of peace and crisis”, said IHF President, Dr Francisco Balestrin. “On 8 November, we will recognize hospitals and healthcare organizations from around the world for their outstanding and innovative programs to improve patient experience and outcomes during the 2019 IHF Awards Ceremony.” Six keynote presentations will feature world-renowned speakers followed by insightful panel discussions. There are 130 speakers to offer fresh perspectives and strategies from their experiences, as well as examples of current innovations and digital transformations in healthcare from different regions in the world. If you are interested in resilient health services, you can hear about the challenges of refugee crisis in Palestine from Dr. Akihiro Seita, Director of Health Programme of UNRWA. You can attend sessions covering terrorist attack situations, response and mitigation plans, and how to maintain quality in healthcare even in the most challenging of times,” offered Dr Balestrin. Topics on health investment for prosperity are spread throughout the four days. Keynote presentations by Dr. Melinda Estes, President and CEO of Saint Luke’s Health System in the USA, and Dr. Agnés Soucat, Director of Health Systems Governance and Financing at WHO Switzerland, will tackle the roles of hospitals, health systems and health services in driving prosperity and in support of population well-being. More sessions under this sub-theme will cover how local hospitals are reinventing themselves and rethinking their plans to improve population health. “If you are keen about innovation for health impact, a keynote session with Sir Andrew Dillon CBE, Chief Executive of the National Institute for Health and Care Excellence (NICE) in the UK, will discuss about the innovation pathway being an alignment between ambition and successful adoption of new health technologies. You can also listen to sessions sharing about the digital ecosystem of Catalonia, the Asian perspective of digital transformation pathway, as well as a presentation of Oman’s e-health achievements”, invited Dr Balestrin. “This is a great opportunity to learn from each other and share ideas over these four days in the conversation on how we can make healthcare more responsive, supportive and prospective in times of peace and crisis,” commented Dr Al Salmi.https://worldhospitalcongress.org
mylene.dayola@ihf-fih.org
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:35:292020-08-26 14:35:42Health leaders from around the world gather in Muscat for the 43rd World Hospital Congress
The European Society of Radiology (ESR) has renewed its initiatives to harmonize medical training for radiologists across Europe. Following advocacy on the part of the radiology community, in close coordination with the European Union of Medical Specialists (UEMS), after the modernization of the Professional Qualifications Directive in 2013, the current political climate offers new opportunities for adapting the legal framework regulating the free movement of doctors and recognition of professional qualifications.
Considering the ongoing evaluation of the Professional Qualifications Directive, the ESR brings again to the attention of the European Commission its twofold request to change Annex V, Section 5.1.3. in order to safeguard the highest standards of medical training and patient care throughout Europe.
Once again, the ESR has joined forces with the UEMS, the authority on medical education in Europe, demonstrating its continuous commitment to collaborating with partner organizations on the harmonization of medical education.
In an official letter submitted to the European Commission, the ESR strongly urges the European Commission to adopt a delegated act to increase the minimum years of training for radiologists from four to five years, in full compliance with the European Training Curriculum for Radiology that was developed to further harmonize radiology education throughout Europe.
Growing training needs and the introduction of digital solutions in medical imaging require equally high standards of training that can only be met by implementing a full-fledged five-year radiology training.
In addition, the ESR calls on the Member States and the European Commission to change the name of the discipline from “Diagnostic Radiology” to “Radiology”, reflecting the profession’s current practice comprising both diagnostic and interventional procedures.
As Member States hold the competence to unilaterally enter the name of a profession into Annex V, individual Member States are strongly encouraged to unilaterally enter “Radiology” as the name of the discipline as a first step towards harmonization. Nevertheless, the ESR believes that an EU-wide solution is needed and therefore urges the Member States and the European Commission to enter into dialogue in the interest of the free movement of radiologists in Europe.
The ESR supports a multi-layered approach, simultaneously launching initiatives at national and EU levels, to strengthen the voice of radiology in the debate. Therefore, the ESR counts on the national radiological societies to be the messenger of the unified radiology position towards national Ministries of Health and health authorities.
Only a coordinated approach involving the ESR and its institutional members can lead to the highest standards and a true harmonization of radiology training and enhance the mobility of the radiology profession in Europe.
https://tinyurl.com/y2q4m5ht
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:35:292020-08-26 14:35:51Renewed ESR advocacy for the harmonization of the radiology profession
In one of the most ambitious collaborative initiatives ever undertaken by the pharmaceutical industry, more than 20 leading biopharmaceutical companies in early July announced the launch of the AMR Action Fund, a ground-breaking partnership that aims to bring two to four new antibiotics to patients by 2030. These new treatments are urgently needed to address the rapid rise of antibiotic-resistant infections – or antimicrobial resistance (AMR).
The companies have raised so far nearly US$1 billion to support clinical research of innovative new antibiotics that address the most resistant bacteria and life-threatening infections. Through the AMR Action Fund, pharmaceutical companies will join forces with philanthropies, development banks, and multilateral organizations to strengthen and accelerate antibiotic development. The Fund will focus on urgent public health needs. It will provide much needed financial resources, as well as important technical support to help biotech companies bring novel antibiotics to patients.
The AMR Action Fund, an initiative of the international body representing the R&D pharmaceutical industry (International Federation of Pharmaceutical Manufacturers & Associations, IFPMA), was announced at simultaneous virtual launch events in Berlin, Germany, and Washington, D.C., USA, on 9 July, with a third event in Tokyo, Japan on July 10.
AMR is a looming global crisis that has the potential to dwarf COVID-19 in terms of deaths and economic costs.
Commenting on the Fund, Dr Tedros Adhanom Ghebreyesus, Director General World Health Organization, said: “AMR is a slow tsunami that threatens to undo a century of medical progress. I very much welcome this new engagement of the private sector in the development of urgently-needed antibacterial treatments. WHO looks forward to working with the AMR Action Fund to accelerate research to address this public health crisis.” New antibiotics The world urgently needs new antibiotics, but there are few in the pipeline because of a paradox: despite the huge societal costs of AMR, there is currently no viable market for new antibiotics. New antibiotics are used sparingly to preserve effectiveness, so in recent years, a number of antibiotic-focused biotechs have declared bankruptcy or exited this space due to the lack of commercial sustainability, resulting in the loss of valuable expertise and resources. The consequence is a huge public health need for new antibiotics, but a lack of funding available for antibiotic R&D, particularly the later stages of clinical research. This creates a “valley of death” between discovery and patient access.
“With the AMR Action Fund, the pharmaceutical industry is investing nearly US$1 billion to sustain an antibiotic pipeline that is on the verge of collapse, a potentially devastating situation that could affect millions of people around the world,” said David Ricks, Chairman and CEO of Eli Lilly and Company and President of IFPMA. “The AMR Action Fund will support innovative antibiotic candidates through the most challenging later stages of drug development, ultimately providing governments time to make the necessary policy reforms to enable a sustainable antibiotic pipeline.”
With this investment, the AMR Action Fund will be the largest collective venture ever created to address AMR. The AMR Action Fund will:
Invest in smaller biotech companies focused on developing innovative antibacterial treatments that address the highest priority public health needs, make a significant difference in clinical practice, and save lives.
Provide technical support to portfolio companies, giving them access to the deep expertise and resources of large biopharmaceutical companies, to strengthen antibiotic development, and support access and appropriate use of antibiotics.
Bring together a broad alliance of industry and non-industry stakeholders, including philanthropies, development banks, and multilateral organizations, and help encourage governments to create market conditions that enable sustainable investment in the antibiotic pipeline.
The Fund is expected to be operational during the fourth quarter of 2020.
For more details on the AMR Action fund, visit www.AMRactionfund.com
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:35:292020-08-26 14:35:31Biopharma companies invest $1bn in new AMR Action Fund to save collapsing antibiotic research pipeline
A Loughborough University academic is providing guidance to clinicians who are likely to be having – and training people who will have – difficult conversations with patients suffering from COVID-19 or those closest to them.
Professor Ruth Parry, an expert in healthcare communication and interaction, has outlined a series of evidence-based principles with the help of her Loughborough colleague Becky Whittaker, Sharan Watson, of the University of Derby, and Dr Ruth England, of Royal Derby Hospital.
The team shared the recommendations with NHS Health Education England and these have been used to develop a series of open access resources that aim to support healthcare staff who will be having difficult conversations in relation to the coronavirus.
The principles, which have also been added to the International Association for Hospice and Palliative Care’s COVID-19 resources list*, are based on research by Professor Parry and other communication scientists worldwide who have recorded and analysed thousands of difficult conversations across various health and social care settings in the UK, Australia, Japan, and the US.
Professor Parry, who receives funding from the National Institute for Health Research (NIHR), says her guidance steers away from providing recommended phrases or scripts as it is important to equip health workers with the tools to communicate flexibly according to individual circumstances.
Having a conversation by phone, conversations where the staff member who is to do the talking is wearing PPE (Personal Protection Equipment), and conversations with people who have varying degrees of knowledge and distress are all examples of circumstances that can impact how a conversation should be constructed.
What’s more, Professor Parry says giving difficult news over the phone or when wearing Personal Protection Equipment are circumstances that staff would normally want to avoid – in normal circumstances, the health services strive to ensure that these difficult conversations are led by highly experienced professionals, face-to-face, and in calm environments.
Professor Parry has divided her advice into key areas. They include (with a brief overview of what they cover):
Prepare yourself and the environment as best you can
Health workers should clarify in their mind what they want to say and why, and find a comfortable and private setting, as best they can.
Start the conversation with ‘signposting’
Conversations should be started by giving the person on the receiving end an outline of what will follow – for instance, if it is an update, and/or that there is a decision to be made.
How to show compassion and empathy throughout
This can be portrayed through tone of voice, phrases that attend to emotion, and showing understanding without claiming one can possibly fully understand how the person on the receiving end is feeling.
What does the person you are talking to know, expect, and feel?
Health workers should find out what the person they are talking to already knows and how they feel about it as this will help them fit what they go on to say to the individual person they are talking to.
Are they with someone, can they talk to someone afterwards?
If this is a phone call, finding out who is with a person or who they could talk to afterwards is important, says Professor Parry, but this question should not be asked right at the start of a conversation as it could easily be heard as very bad news. Even when there is very bad news to come, building towards it gradually is better than clearly signalling it from the start; a gradual move towards the news reduces the risk of sending the person on the receiving end into severe shock.
Bring the person (further) towards an understanding of the situation – how things are, what has happened or is likely to happen
Professor Parry’s advice is to describe some of the things that are wrong with the unwell person, in such a way that the person speaking is forecasting that bad news is going to come. The point is to bring about gradual recognition, rather than shock.
Dealing with crying
Deliveries should be modified to be softer and more lilting if this happens. Speakers should allow silence, repeat brief further sympathy – ‘I’m so sorry’, and acknowledge the distress before moving on and giving more information.
Moving towards the end of the conversation with ‘screening’ – ‘are there things you would like to ask, that I have not said, or explained enough?’
Phrases like ‘anything else’ should be avoided because, in some circumstances, this can be interpreted as the speaker not expecting there to be anything else. Offering ‘Are there things I have not covered or explained enough?’ removes the implication that the person has not understood things.
Moving towards the end of the conversation with words of comfort and attention to what happens next
If possible, health workers should try to deliver something that is of comfort and that they can say truthfully, says Professor Parry. They should also explain what happens next, advise who the person they are talking to can contact for support and, if necessary, explain how pain or other symptoms will be controlled.
Professor Parry has also provided advice to help somewhat reduce the emotional burden on the healthcare worker – for example, she recommends they find someone to debrief with before and after a difficult conversation. Of the importance of the guidance and what she hopes it will achieve, Professor Parry said: “Healthcare workers are now having to have break bad news and have difficult conversations on an unprecedented scale.
“The kind of research I do makes it possible to pin down, to articulate, precisely how skilled, compassionate healthcare staff communicate, and pass this on to others.
“I hope that our guidance will help all staff having to break bad COVID-19 news to patients or their loved ones, to feel confident and able to communicate well, whilst looking after their own wellbeing.”
The full guidance document has been shared on the Real Talk website – a platform for communication training resource designed to use in face-to-face training events for health and social care staff – and can be downloaded as a PDF here.
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:35:292020-08-26 14:35:37COVID-19: Evidence-based advice for health workers having difficult conversations about end of life
The Society for Healthcare Epidemiology of America has issued a new expert guidance on how hospitals and healthcare providers may reduce infections associated with anaesthesiology procedures and equipment in the operating room. The guidance recommends steps to improve infection prevention through increased hand hygiene, environmental disinfection, and continuous improvement plans. “Even though the demands on anesthesia providers make infection prevention best practices more challenging, there are opportunities for improvement,” said Silvia Munoz-Price, MD, PhD, lead author of the guidance and Professor of Medicine at Froedtert & Medical College of Wisconsin. “We describe how the anesthesiology team and hospital leaders can optimize infection prevention in operating room anesthesia, and we give suggestions for the future, including the need for better equipment design.” A growing body of research has shown that contamination in anesthesiology work areas is connected to healthcare-associated infections that put patients at risk. A survey of 49 U.S. and international facilities showed infection control policies and practices are inconsistent. A writing panel—consisting of representatives from SHEA, the American Society of Anesthesiologists (ASA), the Anesthesia Patient Safety Foundation (APSF), and the American Association of Nurse Anesthetists (AANA)—developed the guidance to establish procedures and best practices specific to anesthesia in the operating room The key recommendations include: Hand hygiene should be performed, at a minimum, before aseptic tasks, after removing gloves, when hands are soiled, before touching the anesthesia cart, and upon room entry and exit. The authors also suggest strategic placement of alcohol-based hand sanitizer dispensers. During airway management, the authors suggest the use of double gloves so one layer can be removed when contamination is likely and the procedure moves too quickly to perform hand hygiene. The report also recommends high-level disinfection of reusable laryngoscope handles or adoption of single-use laryngoscopes. For environmental disinfection, the guidance recommends disinfecting high-touch surfaces on the anesthesia machines, as well as keyboards, monitors and other items in work areas in between surgeries, while also exploring the use of disposable covers and re-engineering of the work surfaces to facilitate quick decontamination in what is often a short window of time. IV drug injection recommendations include using syringes and vials for only one patient; and that injection ports and vial stoppers should only be accessed after disinfection. The authors suggest that implementation of the recommendations requires multi-level collaboration within the hospital, regular monitoring, and evaluation of infection prevention practices with regular feedback for providers as well as clarity in expectations about behaviours. According to the guidance, leadership should define goals, remove barriers to infection prevention, and empower practitioners to meet standards. ASA President Linda Mason, MD, FASA, said the collaboration between anesthesiology and infection prevention is critical to patient safety: “These guidelines address the evidence base for infection prevention while taking into account the realities of the operating room and the complexities involved in providing anesthesia services.” ASA supports local hospital-level discussions and decision-making regarding the use of laryngoscopes, including disinfection procedures per the manufacturer’s recommendations or use of disposable tools, and emphasizes that practices and local administrators should follow any and all updates to the U.S. Pharmacopeia Chapter, expected in the coming months.
SHEAhttps://tinyurl.com/y52mtrzu
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:35:292020-08-26 14:35:45New guidance outlines recommendations for infection control in anesthesiology
We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.
Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.
Essential Website Cookies
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.
We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.
We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.
.
Google Analytics Cookies
These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.
If you do not want us to track your visit to our site, you can disable this in your browser here:
.
Other external services
We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page
Google Webfont Settings:
Google Maps Settings:
Google reCaptcha settings:
Vimeo and Youtube videos embedding:
.
Privacy Beleid
U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.